NCT03649204

Brief Summary

Peripheral arterial disease (PAD), a disabling condition, affects 800,000 Canadians. People with PAD suffer from poor quality of life due to leg pain, which makes walking difficult. They also have a high risk of heart disease. In November of 2017, the University of Ottawa Heart Institute (UOHI) launched Canada's first specific walking rehabilitation and cardiovascular risk reduction program dedicated to patients with PAD. An on-site, supervised exercise program to improve walking endurance and quality of life in PAD has been shown to be successful. However many patients are not able to participate in the on-site program due to barriers such as transportation, parking, or other commitments. Recently, a home-based walking program has also been shown to significantly improve walking endurance and quality of life among people with PAD. It was decided that a hybrid program, that has a short on-site program followed by a home-based program may allow more patients to participate and have the highest chance of success. The goal is to develop a new hybrid program for medical care in PAD patients in order to: (a) improve their walking distance, (b) improve their quality of life and (c) improve their cardiovascular risk. As part of this study the investigators will enrol 25 participants with PAD. Participants will be studied at baseline (before their first on-site class) and at 3 month follow up (after their last home program phone call).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 23, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 28, 2018

Completed
11 months until next milestone

Study Start

First participant enrolled

July 9, 2019

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

May 6, 2026

Status Verified

April 1, 2026

Enrollment Period

5.2 years

First QC Date

August 23, 2018

Last Update Submit

April 29, 2026

Conditions

Keywords

PAD

Outcome Measures

Primary Outcomes (1)

  • 6MWT

    Improvements (increase) in 6 minute walk test total walking distance (meters) after 3 months

    at 3 month follow up

Secondary Outcomes (2)

  • Improvements in quality of life

    at 3 month follow up

  • improvements in Walking Impairment Questionnaire

    at 3 month follow up

Interventions

HY-PADBEHAVIORAL

Hybrid intervention that includes supervised on-site and home-based components in people with PAD

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants who enroll in the UOHI PAD walking program

You may qualify if:

  • Intermittent claudication with PAD documented by:
  • ABI ≤0.90 or \>1.40;(14) or
  • Anatomic evidence of lower extremity arterial stenosis ≥50% (by lower extremity angiography, CT angiography, MR angiography or ultrasound)
  • Ability to participate in the study (ability to walk)
  • Willingness to provide informed consent

You may not qualify if:

  • They have had previous lower extremity amputation
  • They are unable to walk
  • They have critical limb ischemia or open lower extremity wounds.
  • Patient is unable to read and understand English or French
  • Patient is unable, in the opinion of the qualified investigator or referring physician, to comprehend and participate in the exercise intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Ottawa Heart Institute

Ottawa, Ontario, K1Y 4W7, Canada

Location

MeSH Terms

Conditions

Peripheral Arterial Disease

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular Diseases

Study Officials

  • Thais Coutinho, MD

    Ottawa Heart Institute Research Corporation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2018

First Posted

August 28, 2018

Study Start

July 9, 2019

Primary Completion

October 1, 2024

Study Completion

October 1, 2024

Last Updated

May 6, 2026

Record last verified: 2026-04

Locations